Log on / register
Feedback | Support | My details

Comments

Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment

Philip H Keiser email, Michael G Sension email, Edwin DeJesus email, Allan Rodriguez email, Jeffrey F Olliffe email, Vanessa C Williams email, John H Wakeford email, Jerry W Snidow email, Anne D Shachoy-Clark email, Julie W Fleming email, Gary E Pakes email, Jaime E Hernandez email and for the ESS40003 Study Team email

BMC Infectious Diseases 2005, 5:2doi:10.1186/1471-2334-5-2

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.